JNJ vs MRK
By Alex · Tickerpine
Johnson & Johnson vs Merck & Co., Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | MRK |
|---|---|---|
| Price | $254.66 | $128.66 |
| Market cap | $613.02B | $317.77B |
| P/E ratio | 29.5 | 36.2 |
| ROE | 26.42% | 18.94% |
| Profit margin | 21.83% | 13.59% |
| Revenue growth | 9.90% | 4.90% |
| Dividend yield | 2.10% | 2.64% |
| Beta | 0.26 | 0.22 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs MRK in plain English
- JNJ is the bigger company — about 1.9× the market cap of MRK.
- JNJ is cheaper on earnings (P/E 29.5 vs 36.2).
- JNJ earns a higher return on equity (26% vs 19%).
- JNJ is growing revenue faster (10% vs 5%).
- MRK has the higher dividend yield (2.64% vs 2.10%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.